Alli Schaper is the CEO & Co-Founder of Into The Multiverse, an education-first ecosystem for all things fungi. Her mission is to rebrand functional mushrooms and encourage collaboration amongst the psychedelics industry. Alli's team created the world's first functional mushroom marketplace, The Multiverse alongside SuperMush, their in-house CPG brand. Alli is passionate about serving as an ally in bringing the future of psychedelics and microdosing to the mainstream wellness conversation.
Joshua Kappel is a founding partner of Vicente LLP, where he has helped shaped cannabis and psychedelic policies over the past 10 years while representing leading companies in these emerging fields. Recently, Joshua co-authored Colorado's Natural Medicine Health Act, and served as chair of Natural Medicine Colorado. Since the NMHA passed, Joshua has been working on implementation through his role as a Senior Advisor to the Healing Advocacy Fund.
Paul F. Austin is an entrepreneur, psychedelic facilitator, and microdosing expert. He has founded two companies in the emerging psychedelic space: Third Wave and Synthesis. Because of his pioneering work at the intersection of psychedelic use, personal transformation, and professional success, Paul has been featured in the BBC, Forbes, and Rolling Stone. Paul sees psychedelic use as a skill, one continuously refined through intentional use, mentorship, and courageous exploration.
As Executive Director, John is dedicated to advancing responsible policy reform, expanding legal access to microdosing, and educating the public on its benefits. He believes microdosing can transform mental health, enhance cognitive performance, and reconnect individuals with purpose. With 25 years of experience in sales, business development, and investment across emerging markets, John excels in navigating complex industries and pioneering new frontiers. Outside of policy, he’s a coach helping entrepreneurs optimize their mindset, performance, and spiritual alignment by integrating ancient wisdom with modern neuroscience.
Stephanie's career as a clinical pharmacologist and researcher transcends traditional boundaries, blending clinical excellence with strategic mindset, and entrepreneurship with artistry. Through her consultancy, Beyond the Bench, she provides expert guidance, open access education, research, and supports initiatives seeking to make a positive impact. Stephanie explores the intersections of psychedelic and plant medicine with neurology, as well as women's health, and rehabilitative therapies. Beyond healthcare, Stephanie has ventured into creating communities centered around music, philanthropy, and the fantastic world of fungi.
Chelsea is a Community Manager and Brand Strategist empowering grassroots psychedelic and wellness brands to expand their influence, build strong communities, and drive meaningful engagement. Drawing on years of clinical research in trauma therapy and expertise in social marketing, she has worked with industry-leading brands like SuperMush, Numinus, and Into the Multiverse. Chelsea advocates for safe, legal access to all healing medicines and is passionate about promoting therapies that foster transformation and inspire others to share their gifts with the world.
Courtney is a devoted social justice attorney and leading trailblazer in drug policy reform, specializing in advising clients on regulatory compliance and risk management in highly regulated, emerging industries. She also serves as Policy Advisor for Decriminalize Nature, General Counsel for the Society for Psychedelic Outreach, Reform, and Education (SPORE), and Advisory Board Member of Heroic Hearts Project, Inc. She was a lead drafter of Denver’s Psilocybin Decriminalization Initiative (I-301) in 2018, and has unparalleled experience implementing state and local policy reform relating to the decriminalization of psychedelics and establishment of cannabis regulatory regimes.
Dr. Evan Lewis is a Neurologist and Clinical Neurophysiologist with expertise in pediatric neurology and epilepsy. He is an Assistant Professor with the Department of Pediatrics at the Hospital for Sick Children and the University of Toronto. Dr. Lewis is the founder and medical director of the Neurology Centre of Toronto (NCT) and VP of Psychedelic Neurology at Numinus – a Canadian company focused on psychedelic research and therapeutics. He joined the Numinus team in September 2021 with an intention to explore the utility of psychedelics in the field of neurology.
Anthony has over a decade of experience in government affairs. His expertise and strategic guidance have brought successful outcomes on behalf of several corporate clients, trade associations, and NGOs. Anthony in known from his unique problem-solving ability on complex issues within California government. He provides tailored solution to clients’ needs in the legislative, budget, and regulatory arenas.
Tracey Tee is the creator and steward of Moms On Mushrooms: one of the fastest-growing digital communities in the psychedelic space. M.O.M. offers a private monthly membership and multiple courses and offerings for working with – and healing through – the sacred use of microdosing psilocybin to mothers worldwide. Tracey was honored to be a guest panelist at the 2023 MAPS Psychedelic Science Conference and has been featured on NPR (twice) the Today Show, Good Morning America, Piers Morgan, Rolling Stone Magazine, CBS Saturday Morning, PBS, Psychedelics Today, ThirdWave Podcast, Psyched with Kaia Roman, NBC News, Romper Magazine, and The London Times. Yes, Tracey did appear on Dr. Phil to defend the right for moms (and anyone, really) to heal through Microdosing. It was the most psychedelic thing she's ever done.
.svg){kind=icon}
